Seasonal Influenza Vaccines- Current Concepts and Future Trends for Effective Immunization


Monday, December 10, 2018   |   10:00 AM PST | 01:00 PM EST   |   Duration: 60 Minutes      

Live

One Dial-in One Attendee

Price: US$150.00


Corporate Live

Any number of participants

Price:US$290.00


Duration: 60 Minutes  

Recorded

Access recorded version,
only for one participant ?

Price: US$190.00

Corporate Recorded

Access recorded version,
Any number of participants ?

Price: US$390.00

In this webinar you will learn how to choose the vaccine for different age groups, Also Recent advances and future developments will be discussed.
Dr. Subodh Bhardwaj   Product Id : 502228
  Instructor : Dr. Subodh Bhardwaj

  More Trainings by this Expert


Overview:

To provide current concepts in seasonal influenza vaccines for the 2018-2019 season

To assess how strain matching and efficacy are linked.
What vaccines are available this season in USA and ROW.
Non egg adapted vaccines.
Trivalent and quadrivalent vaccines.
This years vaccine composition and WHO recommended strains.
Towards a universal Influenza vaccine.

Why should you Attend: The current Influenza season is about to commence and we need to be prepared and informed about the different types of vaccines available in 2018-2019 to be able to immunize children and adults effectively to reduce morbidity and mortality in the USA and globally.

How to choose the vaccine for different age groups. The nasal influenza vaccine. Quadrivalent cell culture vaccine. Non egg adapted influenza vaccines for kids. Recent advances and future developments will be discussed.

Areas Covered in the Session:

  • About the disease epidemiology
  • Current vaccine strains , matching and possible efficacy
  • How to overcome impediments to reduced efficacy to AH3N2
  • Vaccines produced on baculoviruses
  • CDC recommendations
  • Immunization of high risk groups
  • Health economics and savings
  • Storage and vaccine use
  • Rationale
  • Adverse events
  • Summary and conclusions

Who Will Benefit:
  • All those Personnel Associated with Influenza Vaccine
  • Pharmacists
  • Doctors
  • Vaccinologists
  • Nurses
  • Health Personnel
  • Academicians
  • Pediatricians
  • School Health Personnel
  • health Care Consumers
  • Vaccine Companies
  • microbiology Students and Laboratory Personnel
  • Scientists and Researchers
  • Adult Immunization Personnel


Speaker Profile
Dr. Subodh Bhardwaj is a Medical and Scientific Affairs expert and a Senior Scientist with three decades of experience leading research and development of Vaccines and biopharmaceuticals in the pharmaceutical industry.

He has a tenured a diverse range of experience in medical affairs, basic and clinical research and development, clinical trials, Medical and regulatory writing and pharmacovigilance. He is currently working as Clinical Research Consultant with Inventprise LLC, Washington, a company which develops new Innovative vaccines and diagnostics. He qualified as a physician from India in 1981 and having worked in Internal Medicine- he completed MD Clinical Pharmacology from the prestigious AMU, in India in 1991. He then worked as Medical, regulatory director with the Serum Institute of India from 1993 for 15 years where he conducted more than 30 clinical trials for licensure and prequalification including- MMR, DTPwHB, Hib, DTPwHB HIB, Rubella, Measles Rubella, Onco BCG, HDC Rabies vaccines, Infertility drugs,Somatostatin, Somatropin ( Serono). He headed the Pharmacovigilance department and was instrumental in jointly working with WHO Biologicals to conduct large scale epidemiological studies with MMR vaccine and investigate Adverse events to vaccines in different countries like India, Egypt, Chile, Russia, Turkey, Sri Lanka. He subsequently worked with Sanofi Pasteur as Director Medical affairs, Regulatory and Public policy from 2008 to 2011 where he licensed Pentaxim, Menactra, Panenza, and ImovaxPolio vaccines following Phase 3 clinical trials. He holds a Diploma in Pharmacovigilance from Sanofi Pasteur, Lyon (2008). He also worked with Surgipharm Uganda from 2013 to 2015 as Director Medical and Portfolio for several reputed companies, parentrals, specialized feeds, oncology, disinfectants, devices for spine operations and affordable medicines for East Africa where he was involved with Drug Control authorities. He is an avid Medical writer with more than 60 publications in peer reviewed journals and recently published a chapter in” Pharmaceutical Medicine and Translational Clinical Research” published by Elsevier in 2018. He is Member of the British Association of Pharmaceutical Physicians (BRAPP) and European society of Pharmacovigilance (ESOP). He has also worked on Monoclonals for Rabies and consults with reputed global international organizations since 2016 in New York on topics of public health importance. He recently chaired the 11th International Conference and Exhibition on Pharmacovigilance and Drug safety In June 21-22, 2018 at London.




Your Recently Viewed Webinars

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  support@compliance4All.com